Aegle Therapeutics Corp funding
Aegle Therapeutics Corp, a biotechnology company based in Woburn, MA, filed a Form D with the SEC on August 28, 2026 and reported $2.3M raised. It filed 2 new offerings in this period, totaling $2.7M.
Amount raised$2.3M
Offering size$2.3M
Filed with the SECAugust 28, 2026
First saleAugust 4, 2026
IndustryBiotechnology
SecuritiesEquity
LocationWoburn, MA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far17
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 28
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| August 28, 2026 | $2.3M | $2.3M | Equity |
| March 3, 2026 | $456K | $700K | Debt |
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care